Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes.

Deptartment of Rheumatology, Institute of Physical Medicine, University Hospital Zurich, Zurich, Switzerland.
Advances in Experimental Medicine and Biology (Impact Factor: 2.01). 02/2008; 624:55-71. DOI: 10.1007/978-0-387-77574-6_5
Source: PubMed

ABSTRACT Recent evidence suggests that higher vitamin D intakes beyond current recommendations may be associated with better health outcomes. In this chapter, evidence is summarized from different studies that evaluate threshold levels for serum 25(OH)D levels in relation to bone mineral density (BMD), lower extremity function, dental health, risk of falls, admission to nursing home, fractures, cancer prevention and incident hypertension. For all endpoints, the most advantageous serum levels for 25(OH)D appeared to be at least 75 nmol/l (30 ng/ml) and for cancer prevention, desirable 25(OH)D levels are between 90-120 nmol/l (36-48 ng/ml). An intake of no less than 1000 IU (25 mcg) of vitamin D3 (cholecalciferol) per day for all adults may bring at least 50% of the population up to 75 nmol/l. Thus, higher doses of vitamin D are needed to bring most individuals into the desired range. While estimates suggest that 2000 IU vitamin D3 per day may successfully and safely achieve this goal, the implications of 2000 IU or higher doses for the total adult population need to be addressed in future studies.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Vitamin D is essential for bone health. In addition, vitamin D has recently been proposed to play a role in the pathophysiology of many chronic diseases. Despite the large amount of studies published on vitamin D, the threshold for a sufficient serum 25(OH)D concentration is still debated and may differ according to outcomes and subgroups. To estimate thresholds for serum 25(OH)D concentration with respect to different outcomes and for different subgroups. Observational data from the Longitudinal Aging Study Amsterdam were used, an ongoing population-based Dutch cohort study (N=1164, mean (SD) age 75.2 (6.5) years). falling, fractures, hypertension, cardiovascular disease, blood pressure, parathyroid hormone (PTH), grip strength, physical performance, functional limitations, body mass index (BMI) and mortality. To determine thresholds, spline curves were used. Visual inspection and the statistical best fit of the spline regression models were used together to estimate the best estimate of the thresholds. Thresholds for serum 25(OH)D concentrations in the whole sample ranged from 46 nmol/l (PTH) to 68 nmol/l (hypertension). On average, women, the oldest old (≥75 years) and individuals with high BMI (>25kg/m(2)), had lower thresholds compared to men, the youngest old (65-75 years) and individuals with low-to-normal BMI (<25kg/m(2)). The results indicate that thresholds for serum 25(OH)D may vary according to different outcomes and subgroups. This study does not support the high thresholds (>75 nmol/l) as advised by some experts, and the higher requirements in women, older persons and those with high BMI.
    The Journal of Clinical Endocrinology and Metabolism 04/2015; DOI:10.1210/jc.2015-1353 · 6.31 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Asthma is a major public health issue. The co-occurrence of the high prevalence of asthma and vitamin D deficiency documented globally in recent decades has prompted several investigations into a possible association between the two conditions. The objective of this paper was to synthesise the evidence from studies that have measured the association between serum vitamin D and asthma incidence, prevalence, severity and exacerbations. A systematic search of the literature was performed in Pubmed, and the available evidence was summarised both qualitatively and by meta-analysis. Only English language, observational studies measuring serum levels of 25(OH)D as the exposure were included, as this is the most robust measure of vitamin D levels. The search identified twenty-three manuscripts: two case-control, twelve cohort and nine cross-sectional studies. Collectively, the evidence suggests that higher serum levels of 25(OH)D are associated with a reduced risk of asthma exacerbations, but there was little evidence to suggest an association with asthma incidence, prevalence or severity. A significant amount of heterogeneity between study methodology and results restricted the scope for meta-analysis. These results suggest that vitamin D supplementation may be effective for the prevention of asthma exacerbations but the findings need to be confirmed by clinical trials.This article is protected by copyright. All rights reserved.
    Allergy 01/2015; DOI:10.1111/all.12583 · 6.00 Impact Factor
  • Source


Available from